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A CLINICO PATHOLOGICAL PROFILE OF
PEDIATRIC LIVER TUMORS
INTRODUCTION
Primary liver tumors are the third largest group of solid abdominal neoplasms in 
children next to neuroblastoma and Wilms'  tumor28.  Hepatic tumors account for about 
0.5% to 2% of all pediatric neoplasms29. Primary tumors of liver are divided into benign 
and malignant epithelial and non-epithelial neoplasms18.
50  to  60%  of  primary  liver  tumors  in  children  are  malignant  in  which 
hepatoblastoma is most common followed by hepatocellular carcinoma30. Undifferentiated 
embryonal sarcoma of liver is the third most common malignant pediatric liver tumors31. In 
children,  benign  tumors  constitute  only  30%  of  liver  tumors  and  most  are 
hemangioendothelioma, followed by mesenchymal hamartoma20. Hepatocellular adenoma 
is a rare benign tumor in children13.
Childhood liver tumors have received great attention because of their vast histologic 
variety, uncertainty about pathogenesis and classification and difficulties in treatment1.
Benign  tumors  showed  female  preponderance  when  compared  to  malignant 
counterpart. Liver tumors are more common in the right lobe.
The availability of high quality ultrasonography, computerised axial tomography 
and magnetic resonance imaging have allowed us to characterise pediatric liver tumors 
with great precision using non invasive modalities.
REVIEW OF LITERATURE
HISTORICAL REVIEW
The  term  hepatoblastoma  was  proposed  by  Willis  for  all  embryonal  tumors 
containing hepatic epithelial  parenchyma resembling more or less embryonal and fetal 
liver tissue4.
Histological classification of hepatoblastoma was originally proposed by Willis and 
later modified by Ishak and Glunz4.
In 1967 Ishak and Glunz refined the histopathologic criteria for hepatoblastoma. 
Since 1967 it has been generally known that hepatoblastoma arises in the liver of infants 
and  young  children,  whereas  patients  older  than  five  years  of  age  tend  to  develop 
hepatocellular carcinoma. Ishak et al. have made a detailed comparative study of cases of 
hepatoblastoma and hepatocellular carcinoma10.
Kasai and Watanabe classified hepatoblastoma into three histologic type (1) fetal (2) 
embryonal (3) anaplastic7.
Ishak and Glunz, classified hepatoblastoma into two histological types (1) epithelial 
type (2) mesenchymal type (mixed hepatoblastoma)7.
Gonzalez-Crussi  has  described  three  subtypes  (1)  fetal  (2)  embryonal  (3) 
macrotrabecular7.
According to kasai, the fetal type had a better prognosis than the embryonal type, 
whereas anaplastic tumors carried a constantly fatal prognosis7.
Landing proposed that osteoid in mixed hepatoblastoma is an adventitious change, 
related to thrombotic phenomenon, as much as phlebolith form in venous angioma that 
thrombose and subsequently ossify10.
Gonzalez  and Mellissa  disagree  with  this  interpretation  because  contrary  to  the 
experience of Landing and of Denher, they were able to see extensive osteoid formation in 
pulmonary metastases of hepatoblastoma. Myogenic elements were not present in any of 
their cases, were not mentioned by Ishak and Gluntz and myogenic elements were absent 
in 70 cases studied by Kasai and Watanabe10.
Regarding histopathology and prognosis, Ishak and Glunz reported no behavioural 
difference between epithelial and mixed hepatoblastoma in their review of 35 cases4. Lack, 
Neave and Vauter et al. suggested that tumors with a predominance of fetal histology may 
have more favourable prognosis4.
Hepatic artery ligation for hemangioma was first reported by de Lovimier et al9.
In 1970 steroid therapy applied for hemangioendothelioma by Touloukian's9.
Undifferentiated  embryonal  sarcoma   of  the  liver  was  a  rare  primary  hepatic 
malignancy principally affecting patients of pediatric age. It is believed to be a primitive 
mesenchymal neoplasm which usually behaves in a highly malignant fashion2.
Undifferentiated  embryonal  sarcoma  of  liver  was  recognised  as  a  clinico 
pathological entity by Stocker and Ishak in 1978 on the basis of an Armed Forces Institute 
of  Pathology  series.  Histogenesis  of  this  tumor  remains  undetermined  though  the 
possibility of it being a malignant counterpart of mesenchymal hamartoma was raised by 
Stanley and Ishak25.
Lack,  et  al.  reported  only  two  cases  of  hepatic  adenoma  during  57  years  at 
Children's Hospital, Boston13.
Incidence
Primary hepatic neoplasms account for 0.5% to 2% of all pediatric neoplasms and 
comprise a variety of benign and malignant epithelial and mesodermal tumors. Of 716 
cases of the 10 most commonly occurring hepatic neoplasms seen at the Armed Forces 
Institute of Pathology between 1970 and 1999. Hepatoblastoma, hepatocellular carcinoma 
and hemangioendothelioma accounted for almost 65%23.
AGE
Gonzalez-Crussi  studied  21  cases  of  hepatoblastoma  at  Children's  Memorial 
Hospital of Chicago between 1954 and 1981, age range was between 37 hours to 12 years, 
seventeen cases were less than 2 years and three cases were neonates in first 3 months10.
Ernest and Lack et al. reported 54 cases of hepatoblastoma in which age range was 
between 4 month - 4½ years with an average of 17 months4.
Madhusudhana Murthy et al. reported 7 cases of hepatoblastoma in which age range 
was 5 months to 10 years, with an average of 25 months15.
Gandhi et al. reported 6 cases of hepatoblastoma out of which age range was 8 
months to 4 years, with an average of 19 months8.
Jeng Chang Chen et al. studied 55 cases of hepatocellular carcinoma with age range 
of 4 to 16 years at diagnosis with median and mean age of 11 and 10.9 years respectively11.
Yen-Hsuan Ni, studied 71 cases of hepatocellular carcinoma between 1964 to 1989 
in which age range was 3 to 17 years, with an average of 9.7 years30.
WeiJao Chen et al. studied 55 cases of hepatocellular carcinoma between 1976 to 
1985 in which age range was 6 to 15 years. Two peaks in age presentation-first peak was 
between 7 to 9 years and second peak was 12 to 15 years28.
Mistry et al. reported two cases of undifferentiated embryonal sarcoma in which 
both cases were 9 years old17.
Lack et al. reported two cases of hepatocellular adenoma during 57 years at Children 
Hospital, Boston in which one case was in a new born and the other in a two year old 
child13.
Francois et al. reported 16 cases of hemangioendothelioma in which age range was 
birth to 14 years and mean age was 2.3 years6.
Georage et al. reported 16 infants with hemangioendothelioma in which mean age 
was 7 months and median age of 6 week and age range from 2 days to 14 years9.
GENDER
Gonzalez Crussi et al. studied 21 cases of hepatoblastoma in which male, female 
ratio was 13:810.
Lack et al. studied 54 cases of hepatoblastoma and male, female ratio was nearly 
2:1. (37 boys; 17 girls)4.
Gandhi et al. reported 6 cases of hepatoblastoma, were with a male, female ratio was 
5:18.
Khosla et al. reported 14 cases of primary malignant tumor, in which 12 cases of 
hepatoblastoma, with male, female ratio of 11:1 and two cases of embryonal sarcoma was 
reported with male, female ratio of 1:112.
Madhusundhana Murthy et al. reported 7 cases of hepatoblastoma and male, female 
ratio was 2.5:115.
Wei Jao Chen et al. studied 55 cases of hepatocellular carcinoma during 10 years 
period from 1976 to 1985 at National Taiwan University Hospital in Children <15 years, in 
which 34 were male and 10 females in M:F of 3.4:1 and 11 cases of hepatoblastoma, out of 
which 7 were boys and 4 were girls and male, female ratio was 1.7:128.
Jeng Chang Chen et al. studied 55 cases of hepatocellular carcinoma in which 43 
were males and 12 were females and male, female ratio was 3.6:111.
Yen Hsuan Ni, et al. studied 71 cases of hepatocellular carcinoma in a period of 25 
years and male, female ratio was 3.2:1 (M:F 54:17)30.
Mistry et al. reported two cases of undifferentiated embryonal sarcoma, both cases 
were male patients17.
Francois et al. reported 22 cases of benign tumors during 1965 to 1982 at Sainte-
Justine Hospital, in which 16 cases were hemangioendothelioma and male, female ratio 
was 9:136.
George et al. reported 16 cases of hemangioendothelioma, in which male, female 
ratio was 3:59.
Lack et al. during a period of 57 years at Children's Hospital, Boston, reported two 
cases of hepatocellular adenoma and the male, female ratio was 1:113.
STAGING OF TUMOR
Gonzalez-Crussi et al. studied 21 cases of hepatoblastoma at Children's Memorial 
Hospital of Chicago between 1954 and 1981, in which 11 cases were confined to one lobe 
(Stage I), 7 cases were in both lobes (Stage III) and one case was at stage IV with presence 
of distant metastasis. Staging was not done in two cases10.
Ernest et al. studied 54 cases of hepatoblastoma, 28 were confined to right lobe, 7 
involved the left lobe only and 18 involved both lobes4.
Frederic et al. reported 26 cases of hepatoblastoma and 3 cases of hepatocellular 
carcinoma during a 13 years period from 1973 to 1984. In 26 cases of hepatoblastoma, 15 
were confined to right lobe, 8 were confined to left lobe and 3 were bilateral and in the 3 
cases of hepatocellular carcinoma, two cases were in right lobe and one case was in left 
lobe7.
Gandhi et al. reported 6 cases of hepatoblastoma in which 4 cases were confined to 
right lobe and two cases were confined to left lobe8.
Khosla et al. reported 12 cases of hepatoblastoma and two cases of undifferentiated 
embryonal sarcoma from 1982 to 1987 at All India Institute of Medical Sciences, 8 cases 
were confined to right lobe, 3 were involved in both lobes, one was involved in left lobe12.
Madhusudhana Murthy et al. reported 7 cases of hepatoblastoma, in which 5 cases 
involved both lobes, one in the right lobe and other in the left lobe15.
Jeng Chang Chen et al. reported 48 cases of hepatocellular carcinoma, in which 
bilateral involvement was found in 32, left lobe was involved in 9 and right lobe in 711.
Wei Jao Chen et al. reported 55 cases of malignant hepatic tumors, in which one 
was liposarcoma, in 30 cases of histologically proven hepatocellular carcinoma, 23 cases 
involved both lobes, four were confined to left lobe and three were confined to right lobe 
and in 10 cases of histologically proven hepatoblastoma, 4 were in both lobes, 4 were in 
right lobe and 2 were in left lobe28.
Francois  et  al.  reported  22  cases  of  benign  liver  tumors,  16  cases  of 
hemangioendothelioma and 4 cases of mesenchymal hamartoma during 25 years from 
1965 to 1989. The hemangioendothelioma cases were 6 on the left lobe, 5 on the right lobe 
and 5 on both lobes. All the 4 cases of mesenchymal hamartoma, were on the right lobe6.
George et al.  reported 16 cases of hemangioendothelioma during 32 years from 
1955 to 1987. All the cases had diffuse disease9.
Mistry et al.  reported 2 cases of undifferentiated embryonal sarcoma, both were 
confined to right lobe17.
Lack et al. reported 2 cases of hepatocellular adenoma during 57 years, at Children's 
Hospital, Boston. Both cases were confined to right lobe13.
ALPHA FETO PROTEIN
Human AFP is a glycoprotein containing a molecule of biantennary glycan and 
previous studies have shown that some molecular structural differences in the carbohydrate 
chain  exist  according  to  different  sources  of  AFP  synthesis  and  that  such 
microheterogeneity in carbohydrate moiety can be definitely identified by the reactivity 
with lectins. Concanavalin A, lens culinaris hemagglutinin and phytohemagglutinin-E are 
lectins commonly used and based on reactivity to these lectins, AFP from patients with 
hepatic malignancies, benign liver diseases and germ cell tumors can be clearly classified 
into three types in adults. Subfractionation of serum alpha feto protein is a useful method 
to discriminate between yolksac tumors, hepatic malignancies and benign liver diseases in 
adults but has not been validated in infants and children31.
Following surgical resection of pediatric liver tumors, a sharp decrease and return to 
normal  serum  AFP  concentrations  within  approximately  2  months  indicated  the 
completeness of surgical procedure. Importance of the AFP assay in the follow up of post 
surgical resection of tumor for the assessment of the completeness of surgical procedure, 
the prognosis, and the early detection of tumor recurrence is stressed7.
Frederic et al. reported 29 cases of malignant hepatic tumor, in which AFP level 
range from 340ng/ml to 5,30,000 ng/ml and it was normal in three of cases. All patients 
cured had normal values of AFP with in approximately 2 months and never demonstrated 
subsequent  changes.  In  four  cases  after  normal  postoperative AFP levels  a  secondary 
increase in serum AFP was noted 4 to 14 months later. This corresponded to pulmonary 
metastases in two cases and local recurrence in two others.  Persisting high level after 
operation was indicative of residual mass in four cases. There are usually no difficulties in 
diagnosis when the clinical examination and ultrasonogram evidence of an intrahepatic 
mass together with elevated serum AFP level of 1,000 to 10,000 ng/ml (normal 16ng/ml or 
less). Normal serum AFP level may be demonstrated in 10% of hepatoblastoma and in 
10% of hepatocellular carcinoma. Serum AFP may also be elevated in case of hamartoma 
but the levels are usually lower than with malignant tumors. Therefore, biopsies may be 
required if there is doubt concerning the benign or malignant nature of liver tumor, before 
planning any mode of treatment7.
Wei Jao Chen et  al.  reported AFP was elevated in 28 out  of  30 hepatocellular 
carcinoma (93%) and in 8 out of 9 hepatoblastoma children (89%)28.
Francois et al. reported 22 benign tumours during 1965 to 1989 in which AFP levels 
were elevated in 3 of 16 infants with hemangioendothelioma and in 1 child among 4 cases 
of hamartoma. Serum AFP levels were also increased in half of infants who were tested in 
this  series  as  control.  However,  this  may  not  be  significant  because  AFP  levels  are 
normally elevated during the first few week of life6.
George Holcomb et al. found that AFP level was elevated in 3 out of 8 patients of 
hemangioendothelioma but did not correlate with outcome9.
Mistry et al. reported two cases of undifferentiated embryonal sarcoma and in both 
AFP was normal17.
Klein  et  al.  reported  13  cases  of  hepatocellular  carcinoma  and  one 
cholangiocarcinoma  in  people  younger  than  30  years.  In  13  cases  of  hepatocellular 
carcinoma, serum AFP levels was normal in 5 cases, not done in two cases and elevated in 
remaining 6 cases. The range was from 78,000 to 2,202,600 ng/ml27.
Khosla et al. reported serum AFP levels was markedly elevated 1000-10,000 times 
of normal controls in four of the six patients of hepatoblastoma. It was normal in the two 
patients of undifferentiated embryonal sarcoma12.
HISTOLOGIC CLASSIFICATION OF HEPATOBLASTOMA
Gonzalez-Crussi et al. reported 21 cases of hepatoblastoma during 27 years from 
1954  to  1981  in  Children's  Memorial  Hospital  at  Chicago,  in  which  17  (81%)  were 
epithelial type hepatoblastoma, 4 (19%) were mixed (epithelial and mesenchymal). In 17 
epithelial  type  hepatoblastoma,  5  (29.4%)  were  purely  fetal,  4  (23.5%)  were  fetal 
predominant,  3  (17.6%)  were  fetal  and  embryonal  pattern  and  5  (29.5%)  were 
macrotrabecular10.
Lack et al. reported 54 cases of hepatoblastoma during 57 years from 1924 to 1981 
(Table: 1)4.
Table : 1
Histological classification of Hepatoblastoma
♦  Conventional hepatoblastoma
epithelial (59.25%)
    • embryonal predominant 19
    • Fetal predominant 13
Mixed (epithelial and mesenchymal) (22.25%) 12
Indeterminate (9.25%) 5
♦  Anaplastic hepatoblastoma (9.25%) 5
Total 54
Frederic et al. reported 29 cases of malignant hepatic tumor during 13 years from 
1973 to 1984, in which 26 were hepatoblastoma and 3 were hepatocellular carcinoma. One 
of 3 hepatocellular carcinoma was fibrolamellar carcinoma. In 26 cases of hepatoblastoma, 
21 cases were reviewed with Kasai's criteria for hepatoblastoma; only one was of pure 
epithelial type; the others were of mixed type with a predominant fetal component in five 
cases and mixed fetal and embryonal component in 15 cases7.
PROGNOSIS
Age of patients and histopathological subtypes could only indicate outcome, while 
tumor size and serum AFP values were not significantly related to prognosis10.
Lack et al.  reported 49 children with hepatoblastoma of conventional type were 
separated into two groups those who underwent laparotomy and biopsy and those who 
underwent  laparotomy  with  attempt  at  complete  resection.  There  were  no  long-term 
survivors in the first group despite the use of varied adjuvant therapy in nine cases. 13 of 
29 children undergoing routine or extended hepatic lobectomy were alive without evidence 
of disease on an average of 9 years later (range: 16 months-21 years). Among 13 cases 
tumor was confined to one lobe (10 right, three left) in each case. Five of them received 
adjuvent therapy. Hepatoblastoma resected from 11 of 13 survivors was epithelial type 
(85%) with seven having predominantly fetal pattern and two remaining tumors had mixed 
histology with a preponderance of fetal epithelial elements.  None of the children with 
anaplastic tumors survived. Average duration of disease from diagnosis to death for all 
children was 8 months (range: 1 month to 27 months): 82% died in the first year4.
Frederic et al. reported 29 cases of liver malignancies, 26 hepatoblastoma and 3 
hepatocellular carcinoma were treated in a 13 years period. All children were submitted to 
operation but four had nonresectable tumors, even after chemotherapy. Surgery in the 25 
cases consisted of right lobectomy in 14, a left lobectomy in 9 and a tumorectomy in 2. 
Ten children  died,  one  in  the  immediate  post  operative period,  eight  others  from the 
disease and one from a complication of chemotherapy. Follow up for the 18 surviving 
children, all recurrence and metastasis free with normal AFP is less than 2 years for 4 and 
from 2 to 11 years for 147.
Gandhi et al. reported 6 cases of hepatoblastoma in Seth G.S.Medical College. All 
have  undergone  resection.  Since  hepatoblastoma  are  resistant  to  radiotherapy  and 
chemotherapy, the only effective treatment was surgical. In tumors restricted to either right 
or left lobe, resection of involved lobe is a practical procedure. Results of resection of left 
lobe are better than that of resection of right. In this study, 2 children submitted to left 
hepatic  lobectomy  have  done  well  and  one  of  them,  showed  no  evidence  of  local 
recurrence or distant metastasis 6 years after surgery. Three children were submitted to 
right hepatic lobectomy. Two of them did well in the initial post operative period and one 
of them died soon after surgery. One of two, who was doing well post operatively, died of 
a sudden cardiorespiratory arrest on 5th post operative day and the other succumbed to 
broncho pneumonia. A wide wedge excision was carried out in one case. This child did 
well for 1½ years and had no evidence of metastasis. Unfortunately the child was lost for 
followup. It seems that a limited resection may be justifiable and worth while in a selected 
case. Madhusudhana murthy et al. reported 7 cases of hepatoblastoma of which there were 
two survivors after successful resection and another case was showing good response  with 
chemotherapy and was awaiting surgery. Other cases were un resectable bilateral tumor, 
treated only with chemotherapy and lost to followup8.
Jeng Chang Chen et al. studied 55 patients with hepatocellular carcinoma, they were 
divided into three groups: resectable, chemotherapeutic and untreated. The survival data of 
10 children with resectable hepatocellular carcinoma, ranged from 1 month to 171 month, 
4 patients were dead, 5 patients were alive, and one patient lost to followup11.
Wei Jao Chen reported 55 cases of primary malignant tumor of liver in infants and 
children, in which 44 cases were hepatocellular carcinoma, ten cases were hepatoblastoma 
and one was liposarcoma. He observed 60% resectable rate and 40% survival rate for 
hepatoblastoma but for hepatocellular carcinoma, the resectability was less than 10%. Only 
two  children  were  cured  of  hepatocellular  carcinoma.  Among  those  without  tumor 
resection, all except two children died within one year. No difference in survival time was 
observed between those who had chemotherapy and those who did not. Early diagnosis 
and complete excision of tumor remains the only way to long term survival28.
Yes-Hsuan Ni et al. reported 71 cases of hepatocellular carcinoma from 1964 to 
1989 at the National Taiwan University Hospital. Only 10% of the patients survived longer 
than 1 year  after  the onset  of  the initial  symptom. Among 49 patients  who could be 
followed, only two had long term survival over five years, both received surgical resection. 
Observation indicated that  the prognosis  for  children with symptomatic  hepatocellular 
carcinoma is grave, but surgical resection whenever possible, should be carried out30.
Francois et al. reported 22 cases of benign liver tumors between 1965 and 1989. At 
mean follow up of 38 months, 21 of 22 patients were cured or were asymptomatic. The 
96% survival in this series of benign liver tumors contrasts with high mortality rates (90%) 
reported in the literature and illustrates the spectacular improvements that have been made 
in the diagnosis and management6.
George et al. reported 16 cases of hemangioendothelioma from 1955 to 1987 in 
Children's Hospital  of Philadelphia.  The survival  rate in this series was 80%. Highest 
survival in this study was 28 years after diagnosis9.
Mistry et al. reported two cases of undifferentiated embryonal sarcoma, in which 
one was alive four years after surgery and one died 16 months after hepatic resection17.
AIM OF THE STUDY
♦ To study incidence of pediatric liver tumor in Institute of Child Health, 
Chennai during period of 1999 to 2004.
♦ To study clinical behaviour and response of tumor to various mode of 
treatment.
♦ To study alpha feto protein correlation of various liver tumors.
♦ To study histopathological features of pediatric liver tumors.
MATERIALS AND METHODS
The tumor board records and medical records of each patients treated for pediatric 
liver tumors at Institute of Child Health in Chennai from 1999 to 2004 were retrospectively 
reviewed. Details regarding the surgery, clinical features, chemotherapy and follow up 
were collected.
A total number of 39 cases of pediatric liver tumors were taken into study, out of 
which 20 cases were resected specimens and 19 cases were small biopsies.
The specimen had been fixed in 10% neutral buffered formalin immediately after 
removal. The following aspects of gross examination had been under taken.
1. Weight of specimen
2. External surface of tumors
3. Multiple sections of specimen had been made
4. Measurement of tumor was taken.
5. Sections were taken from the tumor, tumor liver interface and from 
adjacent normal liver.
The  bits  were  routinely  processed.  The  sections  were  cut  and  stained  with 
hematoxylin and eosin staining.
The histological features were studied under light microscope. Other details like age, 
sex, onset, duration, size and site were noted. Clinico pathological correlation was done.
RESULTS AND OBSERVATION
This  is  a  histopathological  study  of  39  cases  of  pediatric  liver  tumor  in  the 
Department of Pathology, ICH and HC, Chennai the period from 1999 to 2004.
In  39  cases  of  pediatric  liver  tumors  in  our  study  19  were  small  biopsies.  In 
remaining 20 cases, right lobectomy done in 12 cases, left lobectomy done in 6 cases, 
enucleation done in one case and segmentectomy done in one case.
Table : 2
Histological subtype No. of cases
Hepatoblastoma 28
Hemangioendothelioma 6
Hepatocellular carcinoma 2
Undifferentiated embryonal sarcoma 2
Hepatocellular adenoma 1
Total 39
In our study age range for hepatoblastoma was 4 month to 6 year in 28 out of 39 
cases of pediatric liver tumor, and accounted for 53.5% with peak incidence between the 
age group of 2 months to 24 months.
Table: 3
HEPATOBLASTOMA
Age in years
SEX
Total No. of 
Cases
Male Female
0-1 6 10 16
1-2 2 3 5
2-3 4 1 5
3-4 - 1 1
>5 1 - 1
Total 13 15 28
Table: 4
HEMANGIOENDOTHELIOMA
Age
SEX
Total No. of 
Cases
Male Female
0-1 month - 1 1
1 month - 1 year - 2 2
1-2 years - - -
2-3 years 1 1 2
>3 years - 1 1
Total 1 5 6
Table: 5
HEPATOCELLULAR CARCINOMA
Age
SEX
Location of 
tumor
Male Female
0-5 Years - - -
5-10 years 2 - Right side
Total 2 - 2
Table: 6
UNDIFFERENTIATED EMBRYONAL SARCOMA
Age
SEX
Location of 
tumor
Male Female
0-5 Years - - -
5-10 years 2 - Right side
Total 2 - 2
Table: 7
HEPATOBLASTOMA
Right side 14 cases
Left side 6 cases
Both side 8 cases
Table: 8
HEMANGIOENDOTHELIOMA
Right side 3 cases
Left side 1 case
Both side 2 cases
Only one case of hepatocellular adenoma reported at 6 years in male patient in right 
lobe.
ALPHA FETO PROTEIN LEVEL
• In our study 22 cases of hepato blastoma showed serum AFP level 
range from 280 to 60,000 ng/ml. They were about 20-4285 times of normal. 
Serum AFP level was not done in 6 cases of hepatoblastoma.
• In  one  case  of  hemangioendothelioma  showed  79 times  of  normal 
serum AFP (1108 ng/ml), not done in two cases and normal level in 3 cases.
• In  both  cases  of  hepatocellular  carcinoma,  serum  AFP  level  was 
elevated, around 2140 times of normal.
• Serum AFP level was normal in one case of hepatocellular adenoma 
and in two cases of undifferentiated embryonal sarcoma.
HISTOLOGICAL CLASSIFICATION OF HEPATOBLASTOMA
Table: 9
Epithelial
Purely fetal 12
Fetal and embryonal 12
Anaplastic -
Small cell -
Macrotrabecular 1
Epithelial and mesenchymal 3
Total 28
PROGNOSIS 
In our study out of 39 cases,  follow up study was available only in 6 cases of 
hepatoblastoma and in each one case of hemangioendothelioma, hepatocellular carcinoma 
and undifferentiated embryonal sarcoma.
Maximum 3 year followup without tumor recurrence was available in two cases of 
hepatoblastoma. In both cases complete excision of tumor and adjuvant chemotherapy in 
the form of preoperative in one case and post operative chemotherapy in other case. Both 
cases  were  epithelial  hepatoblastoma,  in  which  one  was  purely  fetal  and  other  was 
combined fetal and embryonal and both cases were confined to left lobe.
In all 6 cases of hepatoblastoma with longer survival more than one year, all were 
stage I tumor (resectable and limited to one lobe and complete excision of tumor was done 
in all 6 cases).
2 year follow up without any recurrence in one case of hepatocellular carcinoma 
was available, in that case preoperative chemotherapy, followed by complete excision of 
tumor was done.
1 year follow up without any recurrence in one case of undifferentiated embryonal 
sarcoma was seen. In that case complete excision and post operative chemotherapy given.
Only with medical treatment with out any surgical treatment, 3 year survival rate 
was seen in one case of hemangioendothelioma.
DISCUSSION
WHO CLASSIFICATION OF PRIMARY LIVER TUMORS AND TUMOR LIKE 
LESIONS
Epithelial tumors or tumor like lesions
Benign
Large regenerative nodule
Lowgrade dysplastic nodule
Highgrade dysplastic nodule
Hepatocellular adenoma
Focal nodular hyperplasia
Bile duct adenoma
Bile duct hamartoma
Biliary cystadenoma
Intraductal biliary papillomatosis
Congenital biliary cyst
Focal fatty change
Malignant
• Hepatocellular carcinoma including fibrolamellar variant
• Combined hepatocellular and cholangio carcinoma
• Cholangiocarcinoma-peripheral, hilar and extra hepatic type
• Biliary cystadeno carcinoma
• Hepatoblastoma
• Intraductal papillary adenocarcinoma
Non-epithelial tumors or tumor like lesions
Benign
• Hemangioma
• Angiomyolipoma
• Infantile hemangioendothelioma
• Mesenchymal hamartoma
• Localized fibrous tumor
• Solitary necrotic nodule
• Inflammatory pseudotumor
• Infectious cyst
• Other rare benign tumors
Malignant
• Epithelial hemangioendothelioma
• Angiosarcoma
• Undifferentiated embryonal sarcoma
• Lymphoma and other hematopoietic tumors
• Kaposi's sarcoma
• Other malignant tumors
CLASSIFICATION OF HEPATIC TUMORS IN CHILDREN
Benign tumors and pseudo tumors
• Hepatocellular
• Focal nodular hyperplasia
• Nodular regenerative hyperplasia
• Hepatocellular adenoma
• Mesodermal
• Infantile hemangioendothelioma
• Mesenchymal hamartoma
Malignant neoplasms
• Hepatocellular
• Hepatoblastoma
• Hepatocellular carcinoma
• Mesodermal
• Undifferentiated embryonal sarcoma
• Angiosarcoma
• Embryonal rhabdomyosarcoma of the biliary tract
STAGING OF HEPATOBLASTOMA
Stage I : Complete resection
Stage II : Microscopic residual tumor
    •  Intra hepatic
    •  Extra hepatic
Stage III : Gross residual tumor
• Primary  completely  resected, 
nodes positive and/or tumor spill.
• Primary  not  completely 
resected, nodes positive and/or tumor spill.
Stage IV : Metastatic disease
• Primary completely resected
• Primary  not  completely 
resected
STAGING  OF  HEPATOBLASTOMA  BY  CHILDREN'S  CANCER  STUDY 
GROUP
Stage I : Localised  tumor  that  was  completely 
resected as primary treatment
Stage II : Localised  residual  tumor  following 
incomplete resection
Stage III : Tumor present in both lobes
Stage IV : Presence of distant metastases regardless of 
the extent of liver involvement.
HISTOLOGICAL CLASSIFICATION OF HEPATOBLASTOMA
I - Epithelial type
A. Fetal pattern
B. Embryonal and fetal pattern
C. Macrotrabecular pattern
D. Small cell undifferentiated pattern
II - Mixed epithelial and mesenchymal type
A. Without teratoid features
B. With teratoid features
GROSS
In our study the average diameter of hepatoblastoma was 8cm (range: 3-14cm). The 
weight of surgically resected specimens ranged from 300 to 1400 gm. Externally, most 
hepatoblastoma were coarsely nodular  with prominent  vascularity and intact  overlying 
Glisson's capsule. On cross section most of the hepatoblastoma were typically variegated 
and has bulging lobules of varying size, colour and consistency (Fig. 1). Tumors were 
often sharply delimited from adjacent liver parenchyma, occasionally giving a spurious 
impression of encapsulation (Fig. 1).
♦ In our study, one case of hemangioendothelioma in 12 days female 
child,  in  which  the  tumor  presented  as  capsulated  exophytic  mass  from 
anterioinferior aspect of left lobe of liver and cut section of tumor was solid 
and hemorrhagic.
♦ In one case of hepatocellular carcinoma, tumor presented as multiple 
nodules throughout the liver, ranging from 3mm-3cm in the background of 
cirrhosis.
♦ Hepatocellular adenoma in our study presented as pedunculated mass 
measuring as 6cm from inferior aspect of right lobe (Fig. 11).
♦ In  our  study,  one  case  of  undifferentiated  embryonal  sarcoma 
presented as solid greywhite nodule protruding into larger space of adjacent 
spongy areas filled with greenish material and blood in some spaces (Fig. 13).
MICROSCOPIC FEATURES
In our study, hepatoblastoma with predominant fetal pattern in which neoplastic 
liver cells were typically arranged in cords or plates from two to three cells thick or had a 
sheet like configuration (Fig. 3). Extra medullary hematopoiesis was noted in fetal area in 
predominant cases of hepatoblastoma (Fig. 2). An acinar or pseudo glandular pattern was 
noted in embryonal areas (Fig. 4).
Osteoid was noted in all 3 cases of mixed hepatoblastoma (Fig. 6), immature spindle 
cells noted in one case and calcification in other case, in our study.
In hemangioendothelioma, the lesion was composed of vascular channels lined by a 
single continuous layer of plump endothelial cells in a supporting fibrous stroma. The area 
was well separated from normal liver parenchyma (Fig. 8).
Hepatocellular carcinoma arised in the background of cirrhosis in one case of our 
study (Fig. 9).
Hepatocellular adenoma composed of sheets of tumor cells in trabeculae, two cells 
thick separated by compressed sinusoids and there were no fibrous septa or portal tracts 
within tumor tissue. The tumor cells were the same size or slightly larger than the normal 
hepatocytes (Fig. 12).
Undifferentiated embryonal sarcoma composed of a mixture of spindled and stellate 
cells in a myxoid stroma. The tumor cells have bubbly light pink cytoplasm (Fig. 14 and 
15).
Cytologic criteria to subtype hepatoblastoma by Ishak and Glunz
Fetal  cell  -  tumor  predominantly  or  exclusively  composed  of  cells  of  obvious 
hepatocytic nature but smaller than hepatocytes of uninvolved liver away from sites of 
compression. N/C ratio of fetal cells is 1/2 to 1/4 (compared to 1/4 to 1/6 in normal liver 
cells),  named  as  fetal  cell,  because  these  cells  resemble  hepatocytes  of  fetus  after 
establishment of the hematopoietic function at 6-8 weeks of gestation10.
Embryonal cell - cells of possible hepatocytic nature but with N/C ratio of 1/1 or 1/2 
morphology and histologic arrangement of embryonal cells are reminiscent of the liver of 
embryos before 6th week of gestation10.
In  mixed  hepatoblastoma  (mesenchymal  and  epithelial  cell);  mesenchymal 
component  was loosely defined as  any mesenchymal  tissue,  other  than blood vessels, 
mature supporting stroma or hematopoietic tissue, that appeared to be an  integral part of 
tumor10.
Anaplasia  defined by Beckwith and Palmer,  as  cells  containing  hyperchromatic 
nuclei  from 3 to  5  times the size  of  neighbouring nuclei,  hyperchromatic  and bizarre 
atypical mitoses with obvious polyploidy10.
Predominant pattern is listed, the histologic appearance that occupied approximately 
2/3 or more of the area of tumor represented on the slides.  If additional pattern were 
present,  but  made  up  less  than  1/3  of  surface  examined,  there  were  listed  as  other 
components,  if  more  than  1/3  they  were  listed  in  combination  with  the  predominant 
pattern10.
Primary hepatic tumors are third largest  group of solid abdominal  neoplasms in 
children next to neuroblastoma and Wilms' tumor28.
50  to  60%  of  primary  liver  tumors  in  children  are  malignant,  in  which 
hepatoblastoma is most common followed by hepato cellular carcinoma. Undifferentiated 
embryonal sarcoma is a rare malignant tumor. Among benign tumors, vascular tumors-
hemangioendothelioma is most common followed by mesenchymal hamartoma. Hepato 
cellular adenoma is a rare benign tumur in children13.
In our study out of 39 cases of pediatric liver tumor from 1999 to 2004 at ICH & HC 
in Chennai and it was compared to AFIP studies (Table 10).
Table: 10
Comparison of incidence of liver tumors
between AFIP23 and our study
Number Percentage (%)
Our Study
1999-04
AFIP 
1970-99
Our 
Study
AFIP
Hepatoblastoma 28 198 71.80 27.6
Hepatocellular carcinoma 2 135 5.13 18.9
Infantile 
hemangioendothelioma
6 119 15.38 16.5
Focal nodular hyperplasia - 72 - 10.1
Mesenchymal hamartoma - 57 - 8.0
Undifferentiated embryonal 
sarcoma
2 52 5.13 7.2
Nodular regenerative 
hyperplasia
- 32 - 4.5
Hepatocellular adenoma 1 27 2.56 3.8
Angiosarcoma - 17 - 2.4
Embryonal 
rhabdomyosarcoma
- 7 - 1.0
Total 39 716 100% 100%
Table: 11
Age distribution of hepatoblastoma in 28 cases in our studies
Age Range No Percentage (%)
In Our Study 0 - 1 year 15 53.5%
1 - 2 year 6 21.5%
2 - 3 year 5 17.8%
3 - 4 year 1 3.6%
> 4 year 1 3.6%
Total 28 100%
Table: 12
Age distribution of hepatoblastoma in 105 cases
from 1970 to 1989 at AFIP23
Age Range No Percentage %
0 - 1 year 36 34.28
1 - 2 year 42 40.00
3 - 5 year 13 12.38
6 - 10 year 8 7.62
11 - 15 year 3 2.86
16 - 20 year 3 2.86
Total 105 100%
Age range in our studies was 4 months to 6 years, average age at presentation was 
19 month.
Lack et al., reported 54 cases of hepatoblastoma in which age range was between 4 
months to 4½ years, average age at presentation was 17 month4.
Gonzalez Crussi et al. reported 21 cases of hepatoblastoma in which age range was 
37 hours to 12 years but 17 cases were less than two years. In our study, 21 out of 28 cases 
were less than 2 years10.
Table: 13
Age distribution of hemangioendothelioma in 6 cases 
Age group Total no. of cases Percentage
0 - 1 month 1 case 16.66%
1 month - 1 year 2 case 33.34%
1 - 2 years - -
2 - 3 years 2 case 33.34%
3 - 4 years 1 case 16.66%
> 4 years 6 case 100%
Table: 14
Age distribution of hemangioendothelioma in 102 cases
from 1970 - 1989 at AFIP23
Age group Total no. of cases Percentage
0 - 1 month 35 case 34.32%
1 - 6 years 55 case 53.92%
7 - 12 years 6 case 5.88%
>1 year 6 case 5.88%
> 4 years 102 case 100%
In our study age range of hemangioendothelioma was 12 days to 39 month, average 
age at presentation was 18 month.
Francois Linkes et al., reported 16 cases of hemangioendothelioma in which age 
range was birth to 14 years and mean age at presentation was 2.3 years6.
George et al., reported 16 cases of hemangioendothelioma in which age range was 2 
days to 14 years and mean age at presentation was 7 month9.
UNDIFFERENTIATED EMBRYONAL SARCOMA (Malignant mesenchymoma)  
In  our  study  two cases  of  undifferentiated  embryonal  sarcoma reported,  age  at 
presentation was 8 years in one and 9 years in other case.
Mistry et al., reported two cases of undifferentiated embryonal sarcoma, both were 9 
years old at presentation17.
HEPATO CELLULAR CARCINOMA
Two cases of hepato cellular carcinoma in our study, age presentation in one case 
was 9 years and 10 years in other.
Yen Hsuan Ni. studied 55 cases of hepatocellular carcinoma between 1964 to 1989 
age range was 3 to 17 years, mean age was 9.7 years30.
One case of hepato cellular adenoma at 6 years reported in our study.
SEX DISTRIBUTION
In our study male female ratio was 1:1.1 for 28 cases of hepatoblastoma.
Gonzelez - Crussi et al., reported 21 cases of hepatoblastoma, in which male, female 
ratio was 1.6:110.
6  cases  of  hemangioendothelioma in  our  study  during  6  years,  in  which  male, 
female ratio was 1:5.
George et al., reported male, female ratio was 3:5 and Francois et al., reported male, 
female ratio was 1:1.5 for hemangioendothelioma9.
Two cases of hepato cellular carcinoma, two cases of un differentiated embryonal 
sarcoma and one case of hepatocellular adenoma in our study was reported only in male.
Mistry et al., reported two cases of undifferentiated embryonal sarcoma and both 
cases were reported in male patients17.
Jeng Chang Chen et al., studied 55 cases of hepatocellular carcinoma in which the 
male, female ratio of 3.5:111.
LOCATION OF TUMORS
Of the 28 cases of hepatoblastoma in our study, 14 were confined to right lobe, 6 
were in left lobe and 8 cases involved both lobes.
Ernest et al., reported 54 cases of hepatoblastoma, 28 were confined to right lobe, 7 
were in left lobe and 18 involved both lobes4.
6 cases of hemangioendothelioma in our study, 2 were in right lobe, two were in left 
lobe and two were in both lobes.
Francois et al., reported 16 cases of hemangioendothelioma in which 6  were in Lt 
lobe, 5 were in Rt lobe and 5 were in both lobes6.
In our study one case of hepatocellular carcinoma was in right lobe and other was in 
both lobes.
Jeng Chang Chen et al., reported 48 cases of hepato cellular carcinoma in which 
bilateral involvement was found in 32, left lobe was involved in 9 and right lobe in seven11.
Both cases of undifferentiated embryonal sarcoma in our study was confined to right 
lobe.
Mistry et al., reported two cases of undifferentiated embryonal sarcoma and both 
were confined to right lobe like our study17.
One case of hepatocellular adenoma in our study was confined to right lobe.
ALPHA FETO PROTEIN
Alpha feto protein level was increased in 22 cases of hepatoblastoma with range 
from 20 to 4285 times of normal in our study. Serum AFP was increased in both cases of 
hepatocellular carcinoma and in one case of hemangioendothelioma.
Serum AFP level was normal in both cases of undifferentiated embryonal carcinoma 
and in hepatocellular adenoma in our study.
Wei Jao Chen et al., reported serum AFP was elevated in 28 out of 30 HCC (93%) 
and in eight out of 9 hepatoblastoma children28.
Francois et al., reported 22 benign tumors during 1965 to 1989 in which AFP levels 
were elevated in 3 to 16 infants with hemangioendothelioma6.
PROGNOSIS
Main mode of treatment for pediatric malignant liver tumor was resection of tumor. 
In  unresectable  tumors  and  in  large  tumors,  pre  operative  chemo therapy  was  given, 
followed  by  surgical  resection.  Post  operative  chemo  therapy  reduces  incidence  of 
recurrence after surgical resection.
In our study, follow up study was available only in 9 cases of pediatric liver tumor, 
in  which  one  was  hemangioendothelioma,  remaining  were  malignant  pediatric  liver 
tumors.
In all eight malignant pediatric liver tumors, complete resection of tumors was done 
and adjuvant therapy in the form of pre operative chemotherapy in some cases and post 
operative chemotherapy in some cases.
Yen Hsuan Ni et al., reported 71 cases of hepatocellular carcinoma, in which he 
observed only two long term survivors among 49 patients who could be followed more 
than 5 years, both received surgical resection. So he quoted prognosis for children with 
symptomatic hepato cellular carcinoma is grave but surgical resection when ever possible 
should be carried out30.
Wei Jaco Chen et al.,  reported 55 cases of primary malignant tumor of liver in 
infants  and  children,  he  observed  60%  resectable  rate  and  40%  survival  rate  for 
hepatoblastoma but for hepato cellular carcinoma, the resectability was less than 10%. He 
observed no difference in survival time between those who had chemotherapy and those 
who did not. Early diagnosis and complete excision of tumor remains the only way to long 
term survival28.
Mistry et al., reported two cases of undifferentiated embryonal sarcoma in which 
one was alive four year after surgery and one died 16 months after surgical resection17.
SUMMARY
Total number of cases of pediatric liver tumors studied during the period of study 
1999 - 2004 in department of Pathology ICH and HC Chennai were 39.
This study has helped us to make following inferences.
1. Hepatoblastoma  was  the  most  common  pediatric  liver  tumors 
accounting for 71.80%.
2. Following hepatoblastoma hemangioendothelioma  was  second  most 
common pediatric liver tumors accounting for 15.38%.
3. Among  malignant  pediatric  liver  tumors,  next  to  hepatoblastoma, 
hepatocellular carcinoma and undifferentiated embryonal sarcoma were each 
accounting for 5.13% in our study.
4. None of tumor like condition like mesenchymal hamartoma and focal 
nodular hyperplasia was reported during our study period.
5. Only  one  case  of  hepatocellular  adenoma was reported during  this 
period.
6. Peak  incidence  of  hepatoblastoma  was  between  birth  to  one  year 
(57%).
7. Only one hepatoblastoma was reported above 5 years.
8. 2 cases of hepatocellular carcinoma and 2 cases of undifferentiated 
embryonal sarcoma in this study was reported above 5 years.
9. In our study male, female ratio for 28 cases of hepatoblastoma was 
1:1.1, in contrast to male preponderance in literature.
10. Male  female  ratio  for  hemangioendothelioma  was  1:5  like  female 
preponderance in literature.
11. In our study pediatric hepatic tumor including benign and malignant 
tumors most commonly involved right lobe of liver.
12. Serum  AFP  level  was  increased  in  hepatoblastoma  and  in 
hepatocellular  carcinoma,  normal  in  hepato  cellular  adenoma  and  in 
undifferentiated embryonal sarcoma. Serum AFP level was increased in few 
cases of hemangioendothelioma.
13. In hepatoblastoma, most common histological subtype was epithelial 
type composed of fetal and embryonal cell, and epithelial type predominantly 
fetal cells, each in 12 cases.
14. Main mode of treatment for pediatric malignant hepatic tumour was 
surgical  resection  whenever  possible  and  pre-operative  chemotherapy  for 
large tumors to reduce size before surgery and also for unresetable tumors. 
Post operative chemo therapy is used to reduce incidence of recurrence.
CONCLUSION
There has been a substantial improvement in survival in patients with pediatric liver 
tumors over 30 years.  Through better  understanding of pathological  diagnosis,  refined 
surgical  staging,  newer  and  more   effective  radiological  techniques  and  standardized 
multimodal  therapies,  a  substantial  number  of  children  diagnosed  with  this  highly 
malignant tumor can expect to survive their disease.
96% survival in benign liver tumors nowadays contrast with high mortality rates 
(90%) reported in the older literature. It illustrates the specular improvements that have 
been made in diagnosis and management.
Nowadays  most  of  hemangioendothelioma  treated  only  with  medical  treatment, 
proposed  longer  survival,  because  more  effective  management  of  congestive  cardiac 
failure.
Despite the remarkable success in the treatment of pediatric liver tumors, there is a 
still  remarkable  percentage  of  patients  who will  suffer  a  relapse,  because  of  surgical 
complication of liver tumors, difficulties in surgical approach to complete resection of 
tumors and decreased effectiveness of chemotherapy when compared to chemotherapeutic 
agent of Wilms' tumor. It  is  challenge  and  goal  of  surgical  pathologists,  pediatric 
surgeons, radiologists and oncologists treating children with liver tumors to improve even 
more the incredible achievement. These challenges to improve the survival of patients with 
liver tumors will be achieved by their continued, collaborative efforts of all the medical 
disciplines involved in the treatment of pediatric liver tumors.
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